Posted on January 19th, 2012 by
Two recent Mayo Clinic studies offer a clearer picture of the rise of hepatocellular carcinoma (HCC), or liver cancer, which has tripled in the U.S. in the last three decades and has a 10 to 12 per cent five-year survival rate when detected in later stages. "The studies illuminate the importance of identifying people with risk factors in certain populations to help catch the disease in its early, treatable stages," said W. Ray Kim, M.D., a specialist in Gastroenterology and Hepatology and principal investigator of one study. Additional coverage: Indian Express, Advocate Hepatitis Blog, Hepatitis C Research and News, News Track India, BringMeTheNews
Times of India, 1/3/2012
You must be logged-in to the site to post a comment.